TLR9 and inflammatory bowel disease: These results indicate that MR inhibited the expression of the pro-inflammatory pathway proteins TLR4 and TLR9, increased the expression of tight junction proteins, and thereby helped maintain intestinal mucosal barrier function in IBD mice.